<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04900779</url>
  </required_header>
  <id_info>
    <org_study_id>PR(AG)569/2020</org_study_id>
    <nct_id>NCT04900779</nct_id>
  </id_info>
  <brief_title>Evaluation of Glycocalyx in Major Abdominal and Thoracic Surgery</brief_title>
  <official_title>Prospective Observational Study to Evaluate Glycocalyx Alteration in Major Abdominal and Thoracic Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Universitari Vall d'Hebron Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital Universitari Vall d'Hebron Research Institute</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background:&#xD;
&#xD;
      The glycocalyx is a fundamental component of the endothelial barrier and alterations at this&#xD;
      level have been shown to exacerbate the inflammatory response in the microcirculation. Its&#xD;
      degradation in the surgical patient, has been tested in interventions that involve regional&#xD;
      or general ischemia, for example in cardiac surgery, major vascular surgery or&#xD;
      transplantation. On interventions that do not involve ischemic events the literature is&#xD;
      limited, such is the case of those patients undergoing major abdominal and thoracic surgery.&#xD;
&#xD;
      Objective:&#xD;
&#xD;
      Assess whether there is a glycocalyx degradation in major elective abdominal and thoracic&#xD;
      surgery, measured as an increase in plasma syndecane-1 levels during the first 24 hours of&#xD;
      postoperative care.&#xD;
&#xD;
      Methodology:&#xD;
&#xD;
      Prospective observational study in patients undergoing major elective thoracic and abdominal&#xD;
      surgery at the University Hospital Vall d´Hebrón. Measurement of the syndecane-1 plasma&#xD;
      levels are going to be done during the first 24 hours after the intervention. It is intended&#xD;
      to evaluate whether its elevation is related to anesthetic perioperative factors, and if it&#xD;
      has an impact con morbildity and mortality in the following 6 months after the procedure.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 2, 2021</start_date>
  <completion_date type="Anticipated">May 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>plasmatic syndecan -1 levels</measure>
    <time_frame>In the first 24 hours after the procedure</time_frame>
    <description>Degradation of glucocalix measured by plasmatic syndecan -1 levels</description>
  </primary_outcome>
  <enrollment type="Anticipated">117</enrollment>
  <condition>Major Elective Abdominal and Thoracic Surgery</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients older than 18 years old that undergo major abdominal and thoracic elective surgery&#xD;
        in University Hospital Vall d´Hebron.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients older than 18 years old&#xD;
&#xD;
          -  Patients that are scheduled to major abdominal and thoracic elective surgery in&#xD;
             Universtity Hospital Vall d´ Hebrón.&#xD;
&#xD;
          -  Patients ASA I, II and III.&#xD;
&#xD;
          -  Patients that after the intervention have their recovering in the Surgical ICU&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients ASA IV and V.&#xD;
&#xD;
          -  Patients that are hospitilized previous to the surgery.&#xD;
&#xD;
          -  Patients that undergo emergent surgery.&#xD;
&#xD;
          -  Patients with Chronic or Acute Renal Failure previous to the surgery.&#xD;
&#xD;
          -  Patients with past medical history of autoinmune disseases.&#xD;
&#xD;
          -  Patients with an active infection previous to the surgery.&#xD;
&#xD;
          -  Patients in treatment with steroids previous to the surgery&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Lysha M Laurens</last_name>
    <phone>+34698209872</phone>
    <email>michelle.laurens.a@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital Universitari Vall d´Hebron</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lysha M Laurens</last_name>
      <phone>+34698209872</phone>
    </contact>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>May 20, 2021</study_first_submitted>
  <study_first_submitted_qc>May 24, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 25, 2021</study_first_posted>
  <last_update_submitted>May 24, 2021</last_update_submitted>
  <last_update_submitted_qc>May 24, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aneurysm, Dissecting</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

